Predictores de malignidad de los nódulos tiroideos

  1. Manuel Penín Álvarez 1
  2. Raquel Miguel Toquero 1
  3. Cristóbal Fraga Abelleira 1
  4. Héctor Hernández Suárez 1
  5. Beatriz San Millán Tejado 2
  6. Alberto Pérez Rodríguez 2
  1. 1 Hospital do Meixoeiro. Vigo
  2. 2 Hospital Álvaro Cunqueiro. Vigo
Revista:
Investigación: cultura, ciencia y tecnología

ISSN: 1889-4399

Ano de publicación: 2022

Número: 28

Páxinas: 22-29

Tipo: Artigo

DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Investigación: cultura, ciencia y tecnología

Referencias bibliográficas

  • Durante. C.; Grani, G.; Lamartina, L.; Filetti, S.; Mandel, S. J.; Cooper, D.S., et al. The diagnosis and managementofthyroidnodules a review. JAMA - J Am MedAssoc. 2018; 319(9): 919-24.
  • Hegedüs, L. TheThyroidNodule. N Engl J Med [Internet]. 2004 Oct 21; 351(17): 1764-71.
  • Galofré, J. C. Incidencia de cáncer de tiroides: el descubrimiento del iceberg oculto. Endocrinol Diabetes y Nutr [Internet]. 2017 Jun; 64(6): 285-7.
  • Brito, J. P.; Al Nofal, A.; Montori, V. M.; Hay, I. D.; Morris, J. C., et al. TheImpactofSubclinicalDisease and MechanismofDetectionontheRise in ThyroidCancerIncidence: A Population-BasedStudy in Olmsted County, Minnesota During 1935 Through 2012. Thyroid [Internet]. 2015 Sep; 25(9): 999-1007.
  • Haugen, B. R.; Alexander, E. K.; Bible, K. C.; Doherty, G. M.; Mandel, S. J.; Nikiforov, Y. E., et al. 2015 American ThyroidAssociation Management Guidelines for Adult Patientswith Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Forceon Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1-133.
  • Rago, T.; Fiore, E.; Scutari, M.; Santini, F.; Di Coscio, G.; Romani, R, et al. Male sex, single nodularity, and youngage are associated with theriskoffinding a papillary thyroid cancer on fine-needle aspiration cytologyin a large series ofpatientswith nodular thyroiddisease. Eur J Endocrinol. 2010; 162(4): 763- 70.
  • Cibas, E. S.; Ali, S. Z. The 2017 Bethesda Systemfor Reporting Thyroid Cytopathology. Thyroid. 2017; 27(11): 1341-6.
  • Nou, E.; Kwong, N.; Alexander, L. K.; Cibas, E. S.; Marqusee, E.; Alexander, E. K. Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration. J Clin Endocrinol Metab. 2014; 99(2): 510-6.
  • Moon, H. J.; Kwak, J. Y.; Choi, Y. S.; Kim, E.-K. Howto Manage Thyroid Nodules With Two Consecutive Non -Diagnostic Resultson UltrasonographyGuided Fine-Needle Aspiration. World J Surg [Internet]. 2012 Mar 7; 36(3): 586-92.
  • Bessey, L. J.; Lai, N. B. K.; Coorough, N. E.; Chen, H.; Sippel, R. S. The Incidence Of Thyroid Cancer fine needle aspiration varies byage and gender. J Surg Res. 2013; 184(2): 761-5.
  • Kwong, N.; Medici, M.; Angell, T. E.; Liu, X.; Marqusee, E.; Cibas, E. S., et al. The Influence Of Patient Age On Thyroid Nodule Formation, multinodularity, and thyroidcancerrisk. J Clin Endocrinol Metab. 2015; 100(12): 4434-40.
  • Schmid, D.; Ricci, C.; Behrens, G.; Letizmann, M. F. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev [Internet]. 2015 Dec; 16(12): 1042-54.
  • Zheng, J.; Li, C.; Lu, W.; Wang, C.; Ai, Z. Quantitative assessment of preoperative serum thyrotropin levels and thyroid cancer. Oncotarget. 2016; 7(23): 34918-29.
  • Golbert, L.; de Cristo, A. P.; Faccin, C. S.; Farenzena, M.; Folgierini, H.; Graudenz, M. S., et al. Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study. PLo S One. 2017; 12(11): 1-12.
  • Boelaert, K.; Horacek, J.; Holder, R. L.; Watkinson, J. C.; Sheppard M. C.; Franklyn, J. A. Serum thy rotrop in concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006; 91(11): 4295-301.
  • Kwak, J. Y.; Han, K. H.; Yoon, J. H.; Moon, H. J.; Son, E. J.; Park, S. H., et al. Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk. Radiology [Internet]. 2011 Sep; 260(3): 892-9.
  • Papini, E.; Guglielmi, R.; Bianchini, A.; Crescenzi, A.; Taccogna, S.; Nardi, F., et al. Risk of malignancy in non palpable thyroid nodules: predictive valueof ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002; 87: 1941-46
  • López, Y.; Penín, M.; San Miguel, P.; Barragáns, M. Riesgo de malignidad de los nódulos tiroideos con atipia de significado incierto. Endocrinol Nutr. 2015; 62(10): 507-10.
  • Fiore, E.; Vitti, P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab. 2012; 97(4): 1134-45.
  • Gharib, H.; Papini, E.; Garber, J. R.; Duick, D. S.; Harrell, M.; Hegedüs, L., et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practicefor the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix. Endocr Pract [Internet]. 2016. May; 22: 1-60.
  • Rinaldi, S.; Plummer, M.; Biessy, C.; Tsilidis, K. K.; Østergaard, J. N.; Overvad, K., et al. Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: The EPIC study. J Natl Cancer Inst. 2014; 106(6).
  • Su, A.; Zhao, W.; Wu, W.; Wei, T.; Ruan, M.; Li, Z., et al. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thy roid cancer in patients with thyroid nodules: A systematic review and meta-analysis. Am J Surg [Internet]. 2020 Sep; 220(3): 634-41.
  • Li, F.; Pan, D.; Wu, Y.; Peng, J.; Li, Q.; Gui, X., et al. Ultrasound characteristics of thyroid nodules facilitate interpretation of th malignantriskof Bethesda system III/IV thyroidn odules and inform therapeutics chedule. Diagn Cytopathol. 2019 Sep; 4 7(9): 881-9U.
  • Belfiore, A.; La Rosa, G. L.; La Porta, G. A.; Giuffrida, D.; Milazzo, G.; Lupo, L., et al. Cancer risk in patients with cold thyroid nodules: Relevance of iodine intake, sex, age, and multinodularity. Am J Med [Internet]. 1992 Oct; 93(4): 363-9.
  • Xu, L.; Port, M.; Landi, S.; Gemignani, F.; Cipollini, M.; Elisei, R, et al. Obesity and the risk of papillary thyroid cancer: A pooled analysis of three casecontrol studies. Thyroid. 2014; 24(6): 966-74.
  • Lai, X.; Zhang, B.; Wang, Y.; Jiang, Y.; Li, J.; Gao, L., et al. Adiposity and the risk of thyroid nodules with a high-suspicion sonographic pattern: a largecross-section al epidemiological study. J Thorac Dis [Internet]. 2019 Dec; 11(12): 5014-22.
  • Brito, J. P.; Gionfriddo, M. R.; Al Nofal, A.; Boehmer, K. R.; Leppin, A. L.; Reading, C., et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: Systematic review and meta analysis. J Clin Endocrinol Metab. 2014; 99(4): 1253-63.
  • Remonti, L. R.; Kramer, C. K.; Leitão, C. B.; Pinto, L. C.; Gross, J. L. Thyroid Ultrasound Features and risk of carcinoma: a systematic review and metaanalysis of observation al studies. Thyroid. 2015 May; 25(5): 538-50
Fonte de datos: Dialnet